NCT07428707 2026-03-13Immune Profiling of CLL/SLL Treated With First-Line PirtobrutinibNational Institutes of Health Clinical Center (CC)Phase EARLY_PHASE1 Recruiting30 enrolled
NCT07205315 2025-12-26A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic AnemiaGrit BiotechnologyPhase EARLY_PHASE1 Recruiting28 enrolled